D. Ross Camidge

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Previous work by Del Re et al. describing the emergence of KRAS mutations following treatment of non-small cell lung cancer patients with EGFR tyrosine kinase inhibitors was inadvertently omitted from the reference list of this Article and should have been cited as follows. The statement in the Results section ‘While it is well established that KRAS(More)
  • 1